Results 171 to 180 of about 462,772 (320)

Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation

open access: yes, 2009
Aim: To compare the effects of one year- long strontium ranelate (SR) and raloxiphene ( R) therapies on bone mineral densities (BMDs) in postmenopausal osteoporotic women.
Banu Kuran   +4 more
core  

Vitamin D Supplementation for Adult Long‐Term Psychiatric Inpatients

open access: yesMental Health Science, Volume 4, Issue 4, December 2026.
ABSTRACT Low vitamin D status is associated with various adverse physical health outcomes including osteoporosis and compromised immune functioning. Emerging research has shown that supplementation can yield selective benefit on symptomatology in serious mental illness. Despite its known benefits, vitamin D screening is not standard in psychiatric care.
G. N. Rustom   +2 more
wiley   +1 more source

Estimating the prevalence of osteoporosis in Australia [PDF]

open access: yes, 2014
This report presents information about the prevalence and impact of osteoporosis in Australians aged 50 and over. Summary Osteoporosis, a common condition among older people, causes bones to become weak.

core  

From Prevention to Healthy Longevity: Evaluating the Multi‐Systemic Effects of Physical Activity and Lifestyle Behaviours in Women

open access: yesReproductive, Female and Child Health, Volume 5, Issue 4, December 2026.
ABSTRACT Purpose Despite spending more on healthcare than any other high‐income nation, the United States faces comparatively poor life expectancy outcomes, primarily due to non‐compliance with preventable and modifiable lifestyle behaviours. This review evaluates the multi‐systemic benefits of physical activity, exercise, diet, weight management and ...
Darah Dilmaghani   +2 more
wiley   +1 more source

The Effect of Yoga Education on Balance and Quality of Life in Postmenopausal Osteoporosis

open access: yes, 2004
Osteoporotic vertebra and hip fractures are major cause of dysfunction, disability, mortality and loss of life quality in our growing and ageing population.
Sevtap Sipahi   +4 more
core  

Bone Anabolic Treatment in Patients With Chronic Kidney Disease: A Systematic Review

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 139, Issue 5, November 2026.
ABSTRACT Background Chronic kidney disease (CKD) associated osteoporosis leads to an increased risk of bone fracture in patients with CKD. Evidence on the efficacy and safety of anti‐osteoporotic medications is limited for this group. This systematic review aimed to examine the efficacy and safety of anabolic parathyroid hormone (PTH) treatment in ...
Huriye Seyma Kafa   +2 more
wiley   +1 more source

A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis [PDF]

open access: yes
Osteoporosis is a major cause of morbidity, mortality and resource cost amongst the elderly population. Hip fracture is the most serious of the osteoporotic fractures, with approximately 10-20% of patients dying within six months of sustaining a fracture.
Bernie O'Brien   +3 more
core  

Higher Bone Mineral Density in Obesity Masks Impaired Bone Remodeling and Disproportionate Musculoskeletal Adaptation in Young Women

open access: yesThe FASEB Journal, Volume 40, Issue 20, 31 October 2026.
Women with obesity exhibited higher total and site‐specific BMD and greater lean mass than lean controls. However, reduced BMD‐to‐fat and lean‐to‐fat mass ratios, increased CTX1 and RANK‐L/OPG, and decreased P1NP and osteocalcin indicated impaired bone remodeling, suggesting that increased BMD masks altered bone turnover and compromised skeletal health.
Yasmin Silva Forte   +8 more
wiley   +1 more source

Ubiquitination of ACSL4 by Parkin Suppresses Ferroptosis and Rescues Glucocorticoid‐Induced Bone Loss

open access: yesAdvanced Science, Volume 13, Issue 56, 9 October 2026.
GCs reduce Parkin, leading to ACSL4 accumulation and PUFA‐phospholipid‐driven ferroptosis in BMSCs, which impairs osteogenesis and promotes adipogenesis, causing GIOP. Parkin restoration (via OE‐Parkin or Parkin‐LNP@DSS6) ubiquitinates and degrades ACSL4, inhibiting ferroptosis, rescuing bone formation, and rescues GIOP bone loss.
Li‐jiang Han   +16 more
wiley   +1 more source

Management of postmenopausal osteoporosis.

open access: yesMalaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 2013
Osteoporosis (OP) is a systemic skeletal disease characterised by low bone mass and micro-architectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. Common sites of osteoporotic fractures are in the spine (vertebral), hip (proximal femur) or wrist (distal forearm).
Yeap SS, Hew FL, Chan SP
openaire   +2 more sources

Home - About - Disclaimer - Privacy